Stay updated on JAK1 Inhibitor With Topical Therapy Clinical Trial
Sign up to get notified when there's something new on the JAK1 Inhibitor With Topical Therapy Clinical Trial page.

Latest updates to the JAK1 Inhibitor With Topical Therapy Clinical Trial page
- CheckyesterdayChange DetectedA new publication citation has been added under the Publications section, referencing a related study on abrocitinib for atopic dermatitis. This expands the study record with related literature without changing the trial's design or status.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page revision tag has been updated to v3.5.4. This is a minor metadata update with no impact on the page content or its use.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s release/revision indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check36 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2; no user-facing content changes observed.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check80 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3; no changes to the study content or listed locations.SummaryDifference0.0%

Stay in the know with updates to JAK1 Inhibitor With Topical Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JAK1 Inhibitor With Topical Therapy Clinical Trial page.